<DOC>
	<DOCNO>NCT02029898</DOCNO>
	<brief_summary>One problem general anesthesia ( GA ) caesarean section place opioid agent . Indeed , literature provide far clear answer regard use opioids prior extraction newborn . Indeed , opioid administration induction beneficial mother ( good control autonomic response noxious stimulus ) , impact newborn unfavorable term adaptation extrauterine life . This especially true birth take place context prematurity / acute fetal distress . The pharmacokinetics remifentanil make opioid consistent rapid sequence induction . Its short period action avoids manual ventilation patient intubation , provide peak action concomitant nociceptive stimulation . Patients high risk aspiration , include pregnant woman , may benefit type morphine induction . In addition , fact remifentanil seem associate relative fetal safety obstetrical neonatal context legitimize development protocol study maternal-fetal consequence use remifentanil induction AG emergency caesarean section . While cesarean section general anesthesia mainly concern premature newborn France , work focus use remifentanil caesarean section context preterm without preeclampsia . The main hypothesis study evaluate safety use remifentanil term adaptation extrauterine life child bear prematurely caesarean section general anesthesia outside context preeclampsia . To , compare two group child , one consist child bear cesarean section general anesthesia maternal remifentanil infusion , make child born cesarean section general anesthesia without maternal infusion remifentanil . This study prospective , single-center , randomize , double-blinded . The primary endpoint form value Apgar score less 7 5 minute , calculate delivery room team support child ( midwife pediatrician ) . The secondary endpoint form maternal hemodynamic parameter ( SBP , DBP , MAP , HR ) , rate complication induction ( difficult intubation , aspiration ) , onset respiratory distress require ventilation mask newborn , rate intubation neonate , rate use adjuvant anesthetic agent .</brief_summary>
	<brief_title>Remifentanil General Anesthesia Context Immaturity</brief_title>
	<detailed_description />
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<criteria>Inclusion criterion mother : Patient 18 year Single pregnancy indication cesarean section general anesthesia context prematurity ( &lt; 37SA ) Patient inform write consent participation research sign Affiliation social security Inclusion criterion child : Parents inform write consent sign father mother participation research child ( unless parent longer parental authority ) Noninclusion criterion mother : Vaginal Delivery Mother pathology require use opioid induction Severe Preeclampsia More 14 week information inclusion Patient guardianship Noninclusion criterion child : Fetal pathology diagnose prenatal period involve prognosis child</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>cesarean section</keyword>
	<keyword>anesthesia</keyword>
	<keyword>child</keyword>
</DOC>